Medigen Vaccine Biologics Statistics

Total Valuation

TPEX:6547 has a market cap or net worth of TWD 13.30 billion. The enterprise value is 11.92 billion.

Market Cap	13.30B
Enterprise Value	11.92B

Important Dates

The last earnings date was Thursday, November 13, 2025.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

TPEX:6547 has 328.75 million shares outstanding. The number of shares has increased by 0.02% in one year.

Current Share Class	328.75M
Shares Outstanding	328.75M
Shares Change (YoY)	+0.02%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.29%
Owned by Institutions (%)	3.43%
Float	252.92M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	22.35
PB Ratio	3.69
P/TBV Ratio	3.71
P/FCF Ratio	n/a
P/OCF Ratio	554.03
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-71.98
EV / Sales	20.04
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-421.51

Financial Position

The company has a current ratio of 14.12, with a Debt / Equity ratio of 0.08.

Current Ratio	14.12
Quick Ratio	10.98
Debt / Equity	0.08
Debt / EBITDA	n/a
Debt / FCF	-10.74
Interest Coverage	-19.08

Financial Efficiency

Return on equity (ROE) is -4.44% and return on invested capital (ROIC) is -2.60%.

Return on Equity (ROE)	-4.44%
Return on Assets (ROA)	-2.50%
Return on Invested Capital (ROIC)	-2.60%
Return on Capital Employed (ROCE)	-4.30%
Revenue Per Employee	5.78M
Profits Per Employee	-1.61M
Employee Count	103
Asset Turnover	0.14
Inventory Turnover	0.58

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +4.39% in the last 52 weeks. The beta is 0.75, so TPEX:6547's price volatility has been lower than the market average.

Beta (5Y)	0.75
52-Week Price Change	+4.39%
50-Day Moving Average	37.73
200-Day Moving Average	43.55
Relative Strength Index (RSI)	56.12
Average Volume (20 Days)	2,682,064

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:6547 had revenue of TWD 594.96 million and -165.64 million in losses. Loss per share was -0.50.

Revenue	594.96M
Gross Profit	330.14M
Operating Income	-167.64M
Pretax Income	-165.64M
Net Income	-165.64M
EBITDA	-47.12M
EBIT	-167.64M
Loss Per Share	-0.50

Full Income Statement

Balance Sheet

The company has 1.68 billion in cash and 303.73 million in debt, giving a net cash position of 1.38 billion or 4.18 per share.

Cash & Cash Equivalents	1.68B
Total Debt	303.73M
Net Cash	1.38B
Net Cash Per Share	4.18
Equity (Book Value)	3.61B
Book Value Per Share	10.97
Working Capital	2.28B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 24.00 million and capital expenditures -52.29 million, giving a free cash flow of -28.29 million.

Operating Cash Flow	24.00M
Capital Expenditures	-52.29M
Free Cash Flow	-28.29M
FCF Per Share	-0.09

Full Cash Flow Statement

Margins

Gross margin is 55.49%, with operating and profit margins of -28.18% and -27.84%.

Gross Margin	55.49%
Operating Margin	-28.18%
Pretax Margin	-27.84%
Profit Margin	-27.84%
EBITDA Margin	-7.92%
EBIT Margin	-28.18%
FCF Margin	n/a

Dividends & Yields

TPEX:6547 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.02%
Shareholder Yield	-0.02%
Earnings Yield	-1.25%
FCF Yield	-0.21%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 3, 2022. It was a forward split with a ratio of 1.48280574.

Last Split Date	Aug 3, 2022
Split Type	Forward
Split Ratio	1.48280574

Scores

TPEX:6547 has an Altman Z-Score of 19.44 and a Piotroski F-Score of 4.

Altman Z-Score	19.44
Piotroski F-Score	4